The 10th International MDM2 Workshop
Description: PMV Pharma is developing first-in-class p53 regulators for the treatment of cancer. PMV Pharma combines unique biological understanding with pharmaceutical development focus.
p53 is activated in response to DNA damage. Mutated p53 proteins lose their wild-type, or normal, tumor suppressing function.
Learn more about the Science of p53
PMV takes a unique approach to restoring mutated p53; structurally correcting the precise geometry of the protein, hence, restoring its tumor suppressing function.
The 10th International MDM2 Workshop